ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 1404 • ACR Convergence 2021

    Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis; A Population-based Study

    jigisha rakholiya1, Mohanad Elfishawi1, Tina Gunderson1, Cynthia Crowson2, Eric Matteson3, Carl Turesson4, Karin Wadström5, Cornelia Weyand1, Matthew Koster1 and Kenneth Warrington6, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Eyota, MN, 3Mayo Clinic College of Medicine and Science, Rochester, MN, 4Lund University, Malm, Sweden, 5Lund University, Malmö, Sweden, 6Mayo Clinic, Rochester, Minnesota

    Background/Purpose: Advancing age, female sex and white race are well-known risk factors for development of giant cell arteritis (GCA). Recent studies suggest that certain metabolic…
  • Abstract Number: 0092 • ACR Convergence 2021

    Clinical Outcomes of Patients with Systemic Rheumatic Diseases Hospitalized for COVID-19 at a Large Academic Center in New York City

    Caroline Siegel1, Jacky Choi2, Debra D'Angelo2, Paul Christos2, Lindsay Lally1, Parag Goyal2, Lisa Mandl1 and Medha Barbhaiya1, 1Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, NY

    Background/Purpose: While patients with systemic rheumatic diseases (SRDs) are in general more vulnerable to infections due to their underlying immune dysregulation and immunomodulatory therapies, data…
  • Abstract Number: 0343 • ACR Convergence 2021

    Overview of the Childhood Systemic Lupus Erythematosus (cSLE) Cohort in the CARRA Registry

    Christine Bacha1, Anne Dennos2, Andrea Knight3, Laura Schanberg4, Mary Beth Son5, Emily von Scheven6, Shahla Amin7, Charles Helmick8 and Aimee Hersh9, 1Nationwide Children's Hospital, Grandview Heights, OH, 2Duke University, Durham, NC, 3Hospital for Sick Children, Toronto, ON, Canada, 4Duke University Medical Center, Durham, NC, 5Boston Children's Hospital, Brookline, MA, 6University of California San Francisco, San Francisco, CA, 7CARRA, Durham, NC, 8Centers for Disease Control and Prevention, Atlanta, GA, 9University of Utah, Salt Lake City, UT

    Background/Purpose: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry is a multi-center, observational registry that collects demographic, clinical, and provider- and patient-reported data from…
  • Abstract Number: 0570 • ACR Convergence 2021

    A Narrowed, but Persistent Mortality Gap: A National, Matched Cohort Study in U.S. Veterans with Rheumatoid Arthritis from 2000-2017

    Tate Johnson1, Yangyuna Yang2, Punyasha Roul2, Brian Sauer3, Joshua Baker4, Ted Mikuls2 and Bryant England2, 1University of Nebraska Medical Center, Elkhorn, NE, 2University of Nebraska Medical Center, Omaha, NE, 3University of Utah, Salt Lake City, UT, 4University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Rheumatoid arthritis (RA) is recognized to increase the risk of premature death. The impact of RA on survival varies across causes of death, though…
  • Abstract Number: 0723 • ACR Convergence 2021

    Size of Regression to the Mean in First-Line Interventions for Osteoarthritis: An Illusion of Effectiveness

    Martin Englund and Aleksandra Turkiewicz, Lund University, Lund, Sweden

    Background/Purpose: Persons who seek treatment for osteoarthritis (OA) are likely doing so when experiencing a flare-up in pain. Due to natural fluctuation of pain, this…
  • Abstract Number: 1035 • ACR Convergence 2021

    The ELSA-Brasil Musculoskeletal Cohort (ELSA-Brasil MSK): Design, Implementation and Prevalence of Chronic Musculoskeletal Pain and Radiographic Knee Osteoarthritis at Baseline

    Rosa Weiss Telles1, Luciana Machado2, Luciana Costa-Silva3 and Sandhi Maria Barreto1, 1Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 2Clinical Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 3Instituto Hermes Pardini. Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

    Background/Purpose: Musculoskeletal (MSK) disorders, including low back pain and osteoarthritis (OA), are ranked among the top causes of years lived with disability and increased risk-attributable…
  • Abstract Number: 1406 • ACR Convergence 2021

    Incidence and General Clinical Features of Giant Cell Arteritis in the ARTESER Multicenter Study

    Jesús T. Sánchez-Costa1, Rafael B. Melero-González2, Elisa Fernández-Fernández3, María T. Silva-Diaz4, Joaquín M. Belzunegui5, Clara Moriano6, Julio Sánchez7, Judit Lluch8, Itziar Calvo9, Vicente Aldasoro10, Lydia Abasolo11, Javier Loricera12, Alberto Ruíz-Román13, Santos Castañeda14, Patricia Moya15, María J. Garcia-Villanueva16, Vanessa A. Navarro-Angeles17, Carles Galisteo18, Anne Riveros-Frutos19, Jose A. Román-Ivorra20, Selene Labrada-Arrabal21, Margarida Vasques-Rocha22, Carlota L. Iñiguez-Ubiaga23, María García-González24, Clara Molina-Almela25, María Alcalde-Villar26, Antonio Juan Mas27, Eugenio De Miguel28, Javier Narvaez29, Miguel Ángel gonzalez-Gay30, Noemí Garrido-Puñal13, Paula V. Estrada-Alarcon17 and Ricardo Blanco31, 1Research unit, Spanish Society of Rheumatology, Madrid, Spain, 2Complejo Hospitalario Universitario de Vigo, Vigo, Spain, 3Rheumatology department, La Paz University Hospital, Madrid, Spain, 4Complejo Hospitalario Universitario de La Coruña, Coruña, Spain, 5Hospital Universitario Donostia, Donostia-San Sebasti, Spain, 6Hospital Universitario de León, León, Spain, 7Hospital Universitario 12 de Octubre, Madrid, Spain, 8Hospital Universitari Bellvitge, Hospitalet de Llobregat, Spain, 9Basurto University Hospital, Bilbao, Spain, 10Complejo Hospitalario de Navarra, Pamplona, Spain, 11Rheumatology Department, Hospital Clínico San Carlos, Madrid, Spain, 12Hospital Universitario Marqués de Valdecilla, Santander, Spain, 13Hospital Universitario Virgen del Rocío, Sevilla, Spain, 14Hospital Universitario de la Princesa, Madrid, Spain, 15Hospital Sant Pau, Barcelona, Spain, 16Rheumatology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain, 17Hospital de Sant Joan Despí Moisès Broggi. Sant Joan Despí, Barcelona, Spain, 18Hospital Universitari Parc Tauli, Saadell, Spain, 19Hospital Germans Trias i Pujol, Badalona, Spain, 20Hospital Universitari i Politècnic La Fe, Valencia, Spain, 21Hospital del Mar, Barcelona, Spain, 22Hospital Universitario Araba, Vitoria-Gasteiz, Spain, 23Hospital Universitario Lucus Augusti, Lugo, Spain, 24Hospital Universitario de Canarias, La Laguna, Spain, 25Rheumatology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain, 26Hospital Universitario Severo Ochoa, Leganés, Spain, 27Rheumatology Department, Hospital Universitario Son Llàtzer, Palma de Mallorca, Spain, 28Hospital Universitario La Paz, Madrid, Spain, 29Division of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 30Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 31Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Epidemiological information on Giant Cell Arteritis (GCA) comes mainly from the Scandinavian countries of northern Europe, which show a higher incidence than the countries…
  • Abstract Number: 0094 • ACR Convergence 2021

    Characteristics Associated with Severe Outcomes in Patients with Systemic Rheumatic Diseases Hospitalized for COVID-19 in New York City

    Caroline Siegel1, Jacky Choi2, Debra D'Angelo2, Paul Christos2, Lindsay Lally1, Parag Goyal2, Lisa Mandl1 and Medha Barbhaiya1, 1Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, NY

    Background/Purpose: Patients with systemic rheumatic diseases (SRD) are potentially at increased risk of severe outcomes from SARS-CoV-2 infection due to their underlying immune dysregulation and…
  • Abstract Number: 0368 • ACR Convergence 2021

    Geographical Prevalence of Family History in Patients with Axial SpA and Its Association with HLA-B27: Data from the Worldwide ASAS-perSpA Study

    Miranda van Lunteren1, Anne Boel1, Clementina López Medina2, Joachim Sieper3, Désirée van der Heijde4 and Floris van Gaalen1, 1Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Reina Sofia Hospital, IMIBIC, University of Cordoba, Cordoba, Spain/ Department of Rheumatology, University of Paris, Cochin Hospital, Paris, France, 3Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 4Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands

    Background/Purpose: Research has shown that in patients with axial spondyloarthritis (axSpA), the most common form of spondyloarthritis (SpA) in a family history is axSpA. Moreover,…
  • Abstract Number: 0571 • ACR Convergence 2021

    The National Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden 2014-2016

    Sofia Exarchou1, Daniela Di Giuseppe2, Gerd-Marie Alenius3, Eva Klingberg4, Valgerdur Sigurdardottir5, Sara Wedrén6, Ulf Lindström7, Carl Turesson8, Lennart Jacobsson7, Johan Askling2 and Johan Karlsson Wallman9, 1Lund University, Malmö, Sweden, 2Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, 3Umeå University, Umeå, Sweden, Umeå, Sweden, 4University of Gothenburg, Gothenburg, Sweden and Sahlgrenska University Hospital, Gothenburg, Sweden, 5Uppsala University, Uppsala, Sweden and Falun Hospital, Falun, Sweden, 6Karolinska Institutet, Stockholm, Sweden and Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 7University of Gothenburg, Gothenburg, Sweden, 8Lund University, Malm, Sweden, 9Lund University and Skane University Hospital, Hjarup, Sweden

    Background/Purpose: Psoriatic arthritis (PsA) incidence estimates vary considerably, and nationwide estimates are sparse. In Sweden, PsA is typically diagnosed in specialized care, although a limited…
  • Abstract Number: 0768 • ACR Convergence 2021

    Poverty and Length of Stay in Children Hospitalized with Pediatric Systemic Lupus Erythematosus: An Analysis of the 2016 Kids’ Inpatient Database

    William Soulsby, Erica Lawson and Matthew Pantell, University of California San Francisco, San Francisco, CA

    Background/Purpose: Prior studies have demonstrated alarming health disparities in adult patients with SLE, including higher disease severity and activity among Hispanic and Black patients. Pediatric…
  • Abstract Number: 1042 • ACR Convergence 2021

    Multimorbidity Prevalence in Systemic Lupus Erythematosus: A Population-Based Study

    Ali Duarte-Garcia1, Maria Valenzuela-Almada2, Mehmet Hocaoglu3, Jesse Dabit1, Shirley-Ann Osei-Onomah1, Sebastian Vallejo-Ramos1, Kurt Greenlund4, Tina Gunderson1, Kamil Barbour4 and Cynthia Crowson5, 1Mayo Clinic, Rochester, MN, 2Division of Rheumatology, Mayo Clinic, Rochester, MN, 3University of Maryland Medical Center, Midtown Campus, Baltimore, MD, 4Centers for Disease Control, Atlanta, GA, 5Mayo Clinic, Eyota, MN

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) have a 3-fold increase in all-cause mortality, compared to the general population. Young patients with SLE are 40…
  • Abstract Number: 1556 • ACR Convergence 2021

    Mortality Rate Related to COVID-19 in Rheumatic and Musculoskeletal Diseases (RMDs)

    Ines Perez - Sancristobal1, Dalifer Freites1, Leticia Lopez Pedraza2, Maria Paula Alvarez Hernandez1, Jose Ignacio Colomer3, Alfredo Madrid - Garcia2, Benjamin Fernandez1, Cristina Vadillo1, Luis Rodriguez Rodriguez4, Arkaitz Mucientes2, Leticia Leon - Mateos2 and Lydia Abasolo5, 1Hospital Clínico San Carlos, Reumathology, Madrid, Madrid, Spain, 2Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Reumathology, Madrid, Spain, 3Fundación para la Investigación Biomedica, Reumathology, Madrid, Spain, 4Hospital Clinico San Carlos, Madrid, Spain, 5Rheumatology Department, Hospital Clínico San Carlos, Madrid, Spain

    Background/Purpose: In patients with rheumatic and musculoskeletal diseases (RMDs) and infected with Covid – 19, a) we want to assess the mortality rate (MR) related…
  • Abstract Number: 0096 • ACR Convergence 2021

    The True Prevalence of SARS-CoV-2 Infection in an Italian Cohort of Patients with Inflammatory Arthritis: A Seroepidemiological Study

    Gabriella Maioli1, Ennio Giulio Favalli2, Elisa Pesce3, Martina Biggioggero2, Mauro Bombaci3, Elena Agape2, Martina Martinovic3, Tanya Fabbris3, Elena Zagato3, Andrea Favalli3, Andrea Gobbini3, Sergio Abrignani3, Renata Grifantini3 and Roberto Caporali4, 1Università degli Studi di Milano, Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Milan, Italy, Milan, Italy, 2ASST Gaetano Pini-CTO Institute, Division of Clinical Rheumatology, Milan, Italy, Milan, Italy, 3Istituto Nazionale Genetica Molecolare, Padiglione Romeo ed Enrica Invernizzi, Milan, Italy, 4Policlinico S. Matteo University, Pavia, Italy

    Background/Purpose: Observational data have shown that rheumatic patients seem not to be more susceptible to SARS-CoV-2 infection neither to worse outcomes. However, the true prevalence…
  • Abstract Number: 0377 • ACR Convergence 2021

    The Prevalence of Inflammatory Back Pain and HLA-B27 in a Large Population-Based Cohort in the Netherlands

    Stan Kieskamp, Suzanne Arends, Elisabeth Brouwer, Hendrika Bootsma, Ilja Nolte and Anneke Spoorenberg, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Chronic low back pain (CLBP; back pain >3 months) with onset at age < 45 and inflammatory back pain (IBP) are regarded as early…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 46
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology